Recent Finacing
Recent Raise
Esphera SynBio engineers exosomes as nanomedicines using synthetic-biology-modified cells expressing proprietary transgenes to produce engineered exosomes for cancer immunotherapies, vaccines, and immunomodulatory therapies.
